Moderna CMO Tal Zaks, MD, PhD, said Oct. 29 the drugmaker is on track to report initial results from its COVID-19 vaccine trial in November, The Hill reported. On an earnings call, Dr. Zaks said ...

The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -1.69% COVID-19 vaccine for adolescents to assess whether the shot may lead to heightened risk of a rare ...

(Reuters) -Moderna said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food and Drug Administration. The company said the submission for ...

Despite quarterly revenue totals that were nearly cut in half compared to the same period last year, Moderna still expects to ...

Moderna said the 860 doses of its COVID-19 vaccine that were stored at the wrong temperature at Springfield (Vt.) Hospital are viable for use, the Vermont Department of Health announced Jan. 28. The ...

CAMBRIDGE, Mass. - Moderna has passed a major milestone on its path to getting its COVID-19 vaccine fully approved by the U.S. Food and Drug Administration. The pharmaceutical company announced ...

Oct 13 (Reuters) - Moderna Inc (MRNA.O), opens new tab said on Tuesday Canada's health ministry will review its experimental COVID-19 vaccine in real time, becoming the third vaccine maker to be ...

The Company's ESG strategy demonstrates its efforts to advance global health and environmental sustainability, as well as its commitments to employees and communities CAMBRIDGE, MA / ACCESSWIRE / ...

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the ...

Nov 16 (Reuters) - Europe's health regulator said on Monday it had launched a real-time review of U.S. drugmaker Moderna Inc's (MRNA.O), opens new tab experimental COVID-19 vaccine, following similar ...